Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tolerability is more important than simplicity for treatment durability.
Trottier B, Machouf N, Huchet E, Lavoie S, Vezina S, Boissonnault M, Charest L, Munoz M, Legault D, Longpré D, Thomas R. Trottier B, et al. Among authors: legault d. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19765. doi: 10.7448/IAS.17.4.19765. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25397509 Free PMC article.
Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57.
Kamya P, Boulet S, Tsoukas CM, Routy JP, Thomas R, Côté P, Boulassel MR, Baril JG, Kovacs C, Migueles SA, Connors M, Suscovich TJ, Brander C, Tremblay CL, Bernard N; Canadian Cohort of HIV Infected Slow Progressors. Kamya P, et al. J Virol. 2011 Jun;85(12):5949-60. doi: 10.1128/JVI.02652-10. Epub 2011 Apr 6. J Virol. 2011. PMID: 21471235 Free PMC article.
Argon plasma coagulation treatment of anal high-grade squamous intraepithelial lesions in men who have sex with men living with HIV: results of a 2-year prospective pilot study.
de Pokomandy A, Rouleau D, Lalonde R, Beauvais C, de Castro C, Coutlée F; Human Immunodeficiency and Papilloma Virus Research Group (HIPVIRG) Study Group. de Pokomandy A, et al. HIV Med. 2018 Feb;19(2):81-89. doi: 10.1111/hiv.12544. Epub 2017 Aug 23. HIV Med. 2018. PMID: 28833949 Free article. Clinical Trial.
Inhibitory Killer Immunoglobulin-like Receptors to self HLA-B and HLA-C ligands contribute differentially to Natural Killer cell functional potential in HIV infected slow progressors.
Kamya P, Tallon B, Melendez-Pena C, Parsons MS, Migueles SA, Connors M, Miconiatis S, Song R, Boulet S, Bruneau J, Tremblay CL, Bernard NF; investigators of the Canadian Cohort of HIV Infected Slow Progressors. Kamya P, et al. Clin Immunol. 2012 Jun;143(3):246-55. doi: 10.1016/j.clim.2012.01.001. Epub 2012 Jan 15. Clin Immunol. 2012. PMID: 22445844 Free article.
33 results